Sign in

You're signed outSign in or to get full access.

Michele A. Chow-Tai

Director at EFSH
Board

About Michele A. Chow-Tai

Independent director (age 60) serving on the board of 1847 Holdings LLC since August 2023, with 32+ years in global banking and financial services. She leads business development, fundraising, and acquisition strategies at Fairview Capital Partners (nearly seven years), and previously spent over two decades at leading global banks; she holds a B.S. from CUNY–York College and is pursuing a J.D. at Mitchell Hamline School of Law . The board classifies her as independent under NYSE American rules .

Past Roles

OrganizationRoleTenureCommittees/Impact
Fairview Capital PartnersBusiness development, fundraising, acquisitions leaderNearly 7 yearsSignificant AUM growth; institutional investor relationships
Leading global banks/financial services firmsVarious leadership roles20+ yearsRisk management, client advisory across global markets
CUNY – York College FoundationBoard Chair10 yearsGovernance leadership for fundraising and strategy

External Roles

OrganizationRoleTenure/StatusNotes
NASP – New York ChapterBoard MemberCurrentDiversity in finance advocacy
NASP–NY FoundationBoard MemberCurrentCommunity and industry engagement
Greater New Haven Chambers of CommerceBoard MemberCurrentRegional business ecosystem engagement
LeaderXXchangeAdvisory Board MemberCurrentDiversity and sustainability in governance

Board Governance

  • Independence: Board determined all directors other than the CEO are independent; Chow‑Tai is independent .
  • Committee membership: Audit Committee member; Audit Committee chaired by Paul A. Froning (members: Froning, Chow‑Tai, Crosnoe, Harris) .
  • Attendance: Board met four times in 2023; each incumbent director attended at least 75% of aggregate board/committee meetings for their service period .
  • Years of service: Director since August 2023 .
  • Governance policies: Board has Corporate Governance Guidelines, Code of Ethics, and Insider Trading Policy (including bans on hedging and pledging without approval) .

Fixed Compensation

Component2023 ActualPolicy (Independent Directors)Notes
Cash retainer$11,667 (pro‑rated for service commencing Aug 2023) $35,000 annual cash, payable monthly No disclosed meeting fees
Equity (RS/RSU/Options)Not disclosed awarded to Chow‑Tai$35,000 annual equity (restricted shares/RSUs/options), subject to Compensation Committee approval Plan share constraints noted; equity grants require Plan capacity

Performance Compensation

Equity Plan FeatureDetailApplicability to Directors
Award typesIncentive/non‑qualified options, SARs, restricted awards (shares/RSUs) Independent directors are eligible under the Plan
Performance criteriaAdministrator may use absolute/relative goals vs peers/indices No director‑specific metrics disclosed
Vesting/transferAwards subject to vesting; non‑transferable (except by will/descent) Terms set by committee
Change‑of‑controlAdministrator may include acceleration provisions in award agreements Not disclosed for director grants
Evergreen/share reserve500,000 authorized; evergreen +5% annually if approved; later increased to 5,000,000 shares (2025 special meeting) Expands capacity for director equity

No director‑specific performance metrics, vesting schedules, or award quantities were disclosed for Chow‑Tai.

Other Directorships & Interlocks

CategoryDetails
Current public company boardsNone disclosed
Private/non‑profit boardsSee External Roles table
Interlocks with competitors/suppliers/customersNone disclosed

Expertise & Qualifications

  • Deep finance and capital markets expertise; track record in fundraising, institutional investor relations, and acquisition strategies .
  • Governance experience through multiple non‑profit boards and advisory roles .
  • Audit committee experience at EFSH; not designated the audit committee financial expert (role held by Froning) .
  • Academic credentials: B.S.; J.D. in progress .

Equity Ownership

MetricAs of Apr 26, 2024As of Jan 22, 2025
Common shares owned0 0
Ownership % of outstanding0.00% (based on 5,292,851 shares) 0.00% (based on 25,400,386 shares)

Insider trading policy prohibits hedging, short sales, and pledging without approval; no pledges or Form 4 activity for Chow‑Tai were disclosed in the proxy materials .

Governance Assessment

  • Positives: Independence, audit committee participation, and satisfactory attendance support board effectiveness and oversight . Formal governance policies and insider trading restrictions enhance investor protection .
  • Alignment concerns: Zero share ownership as of both 2024 and 2025 reduces “skin‑in‑the‑game,” though policy includes annual equity awards subject to committee approval and plan capacity .

RED FLAGS

  • Super‑voting Series E preferred (1,000,000 votes per share) used solely to secure approvals at the 2025 special meeting raises governance optics issues and investor confidence concerns regarding fair shareholder voting dynamics .
  • Aggressive equity plan expansion (evergreen provision in 2024; share reserve increased to 5,000,000 in 2025) could contribute to dilution risk if grants/issuances accelerate; board oversight of dilution mitigation is critical .
  • Frequent warrant reset proposals and large authorized share increase to 2,000,000,000 shares signal capital structure fragility and potential dilution; while not director‑specific, board stewardship, including independent directors, is central to balancing financing needs and shareholder protection .

No related‑party transactions involving Chow‑Tai are disclosed; related‑party dealings predominantly concern the Manager, certain subsidiaries, and officers, and are overseen by the audit committee (which includes Chow‑Tai) .